133 related articles for article (PubMed ID: 18380467)
1. P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity.
Zastre JA; Jackson JK; Wong W; Burt HM
Mol Pharm; 2008; 5(4):643-53. PubMed ID: 18380467
[TBL] [Abstract][Full Text] [Related]
2. Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers.
Zastre J; Jackson J; Burt H
Pharm Res; 2004 Aug; 21(8):1489-97. PubMed ID: 15359586
[TBL] [Abstract][Full Text] [Related]
3. Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity.
Zastre J; Jackson JK; Wong W; Burt HM
J Pharm Sci; 2007 Apr; 96(4):864-75. PubMed ID: 17094135
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers.
Demina T; Grozdova I; Krylova O; Zhirnov A; Istratov V; Frey H; Kautz H; Melik-Nubarov N
Biochemistry; 2005 Mar; 44(10):4042-54. PubMed ID: 15751981
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers.
Zastre J; Jackson J; Bajwa M; Liggins R; Iqbal F; Burt H
Eur J Pharm Biopharm; 2002 Nov; 54(3):299-309. PubMed ID: 12445560
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux.
Dabholkar RD; Sawant RM; Mongayt DA; Devarajan PV; Torchilin VP
Int J Pharm; 2006 Jun; 315(1-2):148-57. PubMed ID: 16616818
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
8. Non-surface activity and micellization of ionic amphiphilic diblock copolymers in water. Hydrophobic chain length dependence and salt effect on surface activity and the critical micelle concentration.
Kaewsaiha P; Matsumoto K; Matsuoka H
Langmuir; 2005 Oct; 21(22):9938-45. PubMed ID: 16229512
[TBL] [Abstract][Full Text] [Related]
9. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.
Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV
Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127
[TBL] [Abstract][Full Text] [Related]
10. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Khdair A; Gerard B; Bachmeier C; Miller DW; Shekhar MP; Panyam J
Mol Pharm; 2007; 4(5):730-8. PubMed ID: 17705442
[TBL] [Abstract][Full Text] [Related]
11. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
12. Computer simulation of architectural and molecular weight effects on the assembly of amphiphilic linear-dendritic block copolymers in solution.
Suek NW; Lamm MH
Langmuir; 2008 Apr; 24(7):3030-6. PubMed ID: 18288872
[TBL] [Abstract][Full Text] [Related]
13. Controlled synthesis and interface properties of new amphiphilic PCL-g-PEO copolymers.
Rieger J; Dubois P; Jérôme R; Jérôme C
Langmuir; 2006 Aug; 22(18):7471-9. PubMed ID: 16922523
[TBL] [Abstract][Full Text] [Related]
14. Interaction of ethylene oxide-propylene oxide copolymers with ionic surfactants studied by calorimetry: random versus block copolymers.
Niemiec A; Loh W
J Phys Chem B; 2008 Jan; 112(3):727-33. PubMed ID: 18081338
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
Collnot EM; Baldes C; Wempe MF; Kappl R; Hüttermann J; Hyatt JA; Edgar KJ; Schaefer UF; Lehr CM
Mol Pharm; 2007; 4(3):465-74. PubMed ID: 17367162
[TBL] [Abstract][Full Text] [Related]
17. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents.
Salama NN; Scott KR; Eddington ND
Int J Pharm; 2004 Apr; 273(1-2):135-47. PubMed ID: 15010138
[TBL] [Abstract][Full Text] [Related]
18. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
[TBL] [Abstract][Full Text] [Related]
19. PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example.
Velluto D; Demurtas D; Hubbell JA
Mol Pharm; 2008; 5(4):632-42. PubMed ID: 18547055
[TBL] [Abstract][Full Text] [Related]
20. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo.
Cornaire G; Woodley J; Hermann P; Cloarec A; Arellano C; Houin G
Int J Pharm; 2004 Jun; 278(1):119-31. PubMed ID: 15158955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]